Orchestra BioMed: Funding, Investors & Team (Oct 2026)
Ensemble BioMed, Inc. is a biomedical development organization zeroed in on growing high effect, high worth, proof based restorative answers for operations that address significant ailments. Its primary spotlight is on growing new treatments for cardiovascular sicknesses which are the main source of death around the world, ending the existences of 17.7 million individuals every year, or 31% of all worldwide passings as indicated by the World Health Organization. It was established in 2017 and is settled in New Hope, Pennsylvania.
Orchestra BioMed has raised $75.0M across 2 funding rounds on record, the most recent an undisclosed round of $35.0M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Orchestra BioMed Company Profile and Key Stats
Latest funding round on record: May 2026.
Orchestra BioMed Funding Rounds
Orchestra BioMed raised $40.0M in a Debt Financing announced in Jul 2022.
3.8 years later, an undisclosed round of $35.0M was announced in May 2026.
Orchestra BioMed Founders and Leadership Team
No contact details are on record for this team yet.
Orchestra BioMed Funding Compared to Other Biotechnology Startups
Orchestra BioMed's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Orchestra BioMed in Biotechnology and New Hope
Companies Similar to Orchestra BioMed
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Orchestra BioMed Funding FAQs
What does Orchestra BioMed do?
Ensemble BioMed, Inc. is a biomedical development organization zeroed in on growing high effect, high worth, proof based restorative answers for operations that address significant ailments. Its primary spotlight is on growing new treatments for cardiovascular sicknesses which are the main source of death around the world, ending the existences of 17.7 million individuals every year, or 31% of all worldwide passings as indicated by the World Health Organization. It was established in 2017 and is settled in New Hope, Pennsylvania.
How much funding has Orchestra BioMed raised?
Orchestra BioMed has raised $75.0M across 2 rounds on record. The most recent is an undisclosed round of $35.0M announced in May 2026.
When did Orchestra BioMed last raise funding?
Orchestra BioMed's most recent funding round on record is an undisclosed round of $35.0M, announced in May 2026.
Who is the CEO of Orchestra BioMed?
David Hochman is listed as CEO at Orchestra BioMed.
Where is Orchestra BioMed headquartered?
Orchestra BioMed is based in New Hope, Pennsylvania, United States.
How many employees does Orchestra BioMed have?
Orchestra BioMed is in the 11-50 employee band.
How does Orchestra BioMed's funding compare to other Biotechnology startups?
Orchestra BioMed's latest round of $35.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Orchestra BioMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orchestra BioMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.